Jun Wang Selected Research

Long Noncoding RNA

4/2024	Immune-related LncRNAs scores predicts chemotherapeutic responses and prognosis in cervical cancer patients.
1/2024	Comprehensive molecular analyses of a 7-m6A-related lncRNAs signature for prognosis, tumor immunity and therapeutic effect in patients with hepatocellular carcinoma.
1/2024	Long noncoding RNA SNHG1 promotes breast cancer progression by regulating the miR-641/RRS1 axis.
1/2024	Interaction between miR‑206 and lncRNA MALAT1 in regulating viability and invasion in hepatocellular carcinoma.
12/2023	LncRNA AGAP2 antisense RNA 1 stabilized by insulin-like growth factor 2 mRNA binding protein 3 promotes macrophage M2 polarization in clear cell renal cell carcinoma through regulation of the microRNA-9-5p/THBS2/PI3K-Akt pathway.
12/2023	Identification of three lncRNA-related prognostic signatures in gastric cancer by integrated multi-omics analysis.
11/2023	MCF2L-AS1/miR-874-3p/STAT3 feedback loop contributes to lung adenocarcinoma cell growth and cisplatin resistance.
1/2023	Long non-coding RNA PSMG3 Antisense RNA 1 is correlated with oral squamous cell carcinoma and regulates cancer cell proliferation by targeting premature microRNA-141.
9/2022	LncRNA TPTEP1 inhibits the migration and invasion of gastric cancer cells through miR-548d-3p/KLF9/PER1 axis.
5/2022	KMT2B promotes the growth of renal cell carcinoma via upregulation of SNHG12 expression and promotion of CEP55 transcription.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun Wang Research Topics

Disease

1132	Neoplasms (Cancer) 07/2024 - 01/2002
243	Inflammation (Inflammations) 04/2024 - 08/2003
222	Infections 05/2024 - 03/2002
167	Breast Neoplasms (Breast Cancer) 04/2024 - 02/2002
152	Neoplasm Metastasis (Metastasis) 04/2024 - 11/2002
118	Lung Neoplasms (Lung Cancer) 04/2024 - 10/2002
118	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 05/2003
96	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 06/2002
89	Hypoxia (Hypoxemia) 05/2024 - 03/2002
87	COVID-19 04/2024 - 01/2020
79	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 05/2007
78	Stomach Neoplasms (Stomach Cancer) 03/2024 - 09/2002
77	Carcinogenesis 02/2023 - 05/2003
73	Prostatic Neoplasms (Prostate Cancer) 12/2024 - 01/2002
71	Wounds and Injuries (Trauma) 04/2024 - 07/2005
67	Carcinoma (Carcinomatosis) 01/2024 - 01/2002
63	Colorectal Neoplasms (Colorectal Cancer) 06/2024 - 03/2007
60	Fibrosis (Cirrhosis) 02/2024 - 12/2005
60	Pain (Aches) 02/2024 - 07/2004
58	Adenocarcinoma of Lung 07/2024 - 05/2009
53	Body Weight (Weight, Body) 04/2024 - 02/2002
51	Human Influenza (Influenza) 12/2023 - 05/2003
48	Parkinson Disease (Parkinson's Disease) 11/2023 - 01/2003
46	Obesity 12/2024 - 10/2007
45	Cognitive Dysfunction 05/2024 - 01/2009
44	Stroke (Strokes) 04/2024 - 08/2005
42	Lymphatic Metastasis 01/2024 - 12/2007
38	Adenocarcinoma 04/2024 - 03/2002
38	Necrosis 02/2024 - 02/2004
37	Sepsis (Septicemia) 05/2024 - 06/2002
37	Leukemia 03/2024 - 01/2002
36	Ischemic Stroke 05/2024 - 05/2012
36	Hemorrhage 03/2024 - 03/2002
36	Type 2 Diabetes Mellitus (MODY) 03/2024 - 05/2004
36	Ischemia 12/2023 - 08/2003
35	Glioma (Gliomas) 04/2024 - 04/2010
35	Renal Cell Carcinoma (Grawitz Tumor) 03/2024 - 08/2010
35	Osteosarcoma (Osteogenic Sarcoma) 02/2024 - 12/2011
35	Disease Progression 01/2024 - 12/2006
33	Hypertension (High Blood Pressure) 05/2024 - 08/2002
33	Neuroinflammatory Diseases 04/2024 - 05/2013
32	Insulin Resistance 03/2024 - 05/2004
31	Esophageal Squamous Cell Carcinoma 01/2024 - 05/2013
30	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 01/2006
29	Reperfusion Injury 04/2024 - 03/2007
28	Atherosclerosis 12/2023 - 04/2008
27	Pneumonia (Pneumonitis) 01/2024 - 01/2010
27	Melanoma (Melanoma, Malignant) 01/2023 - 08/2003
26	Virus Diseases (Viral Diseases) 05/2024 - 04/2005

Drug/Important Bio-Agent (IBA)

408	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2002
252	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2004
121	MicroRNAs (MicroRNA)IBA 02/2024 - 10/2008
119	Messenger RNA (mRNA)IBA 01/2024 - 01/2002
118	CytokinesIBA 03/2024 - 05/2002
88	RNA (Ribonucleic Acid)IBA 06/2024 - 12/2008
85	Therapeutic UsesIBA 03/2024 - 08/2002
77	DNA (Deoxyribonucleic Acid)IBA 08/2023 - 12/2002
75	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 08/2003
74	Small Interfering RNA (siRNA)IBA 03/2024 - 07/2006
73	LipidsIBA 05/2024 - 04/2004
72	Antiviral Agents (Antivirals)IBA 04/2024 - 04/2005
72	Long Noncoding RNAIBA 04/2024 - 05/2012
69	EnzymesIBA 05/2024 - 07/2004
66	Peptides (Polypeptides)IBA 04/2024 - 07/2002
65	VaccinesIBA 03/2024 - 07/2002
59	LigandsIBA 05/2024 - 01/2003
51	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 07/2006
50	AntigensIBA 12/2024 - 10/2002
46	Interleukin-6 (Interleukin 6)IBA 01/2024 - 05/2002
45	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2019
44	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024 - 05/2005
44	IronIBA 01/2024 - 01/2003
43	Transcription Factors (Transcription Factor)IBA 02/2024 - 03/2004
41	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2024 - 01/2002
39	ErbB Receptors (EGF Receptor)IBA 10/2023 - 03/2002
38	AntibodiesIBA 05/2024 - 03/2002
38	Oxygen (Dioxygen)IBA 08/2023 - 03/2002
36	Indicators and Reagents (Reagents)IBA 03/2024 - 12/2006
36	Phosphotransferases (Kinase)IBA 01/2024 - 05/2003
36	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 03/2006
32	CateninsIBA 03/2024 - 01/2013
32	Amyloid (Amyloid Fibrils)IBA 01/2023 - 07/2002
31	Circular RNAIBA 04/2024 - 08/2015
30	Triglycerides (Triacylglycerol)IBA 05/2024 - 03/2011
30	Insulin (Novolin)FDA Link 03/2024 - 05/2004
29	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2024 - 05/2002
27	LipopolysaccharidesIBA 03/2024 - 07/2006
27	PolymersIBA 02/2024 - 04/2003
27	InterferonsIBA 11/2023 - 04/2012

Therapy/Procedure

544	Therapeutics 05/2024 - 03/2002
182	Drug Therapy (Chemotherapy) 04/2024 - 12/2002
110	Immunotherapy 04/2024 - 10/2002
108	Radiotherapy 04/2024 - 12/2002
40	Aftercare (After-Treatment) 04/2024 - 09/2007
37	Transplantation 05/2024 - 06/2002
36	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2024 - 12/2007
35	Stents 03/2024 - 01/2009
35	Chemoradiotherapy 01/2024 - 10/2007
33	Neoadjuvant Therapy 04/2024 - 12/2002
29	Ligation 03/2024 - 11/2006